Skip to content

Predictive Factors for Successful Operative Hysteroscopy Using Tissue Removal Device (TruClear System) Without Anesthesia

Predictive Factors for Successful Operative Hysteroscopy Using Tissue Removal Device (TruClear System) Without Anesthesia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05722028
Enrollment
70
Registered
2023-02-10
Start date
2022-08-01
Completion date
2023-08-31
Last updated
2024-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retained Products of Conception, Uterine Polyp

Brief summary

Background: Small-diameter operative hysteroscopes may allow to perform operative hysteroscopy without general anesthesia in selected patients. One of these instruments is the tissue removal device (TRD), which resects and removes intrauterine pathology such as endometrial polyps and retained products of conception (RPOC) with a diameter of ¬6 mm. Objective: To assess the success rate and intraoperative pain of patients undergoing operative hysteroscopy without anesthesia with the TRD (TruClear Elite Mini-Hysteroscope) for removal of endometrial polyps or RPOC. Methods: Prospective observational study. Participation in the study was offered to patients diagnosed with uterine polyps or RPOC on office diagnostic hysteroscopy. The patients filled out a digital questionnaire before and after the operation. A successful procedure was defined as complete hysteroscopic removal of the uterine pathology using the TruClear system. Oral 400 mcg misoprostol 12 hours before the procedure was prescribed for cervical ripening.

Interventions

PROCEDUREhysteroscopy

Surgical hysteroscopy without anaesthesia for removal of uterine polyp / retained products of conception.

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum

Inclusion criteria

* Diagnosis of polyp or retained products of conception in diagnostic hysteroscopy. * Medical need to remove the finding according to accepted criteria. * Patient's consent to the removal of the finding in a procedure without anesthesia. * Patient's consent to participate in the study.

Exclusion criteria

* Any indication for performing the procedure under anesthesia in an operating room, such as: 1. Medical background requiring operation in an operating room. 2. Personal / mental background requiring procedure under general anesthesia. 3. Cervical stenosis 4. Previous failure to remove the finding in a procedure without anesthesia 5. Lack of response to performing the operation without anesthesia * The lack of response to participate in the study * A known diagnosis of malignancy from a previous sample of the polyp or endometrium

Design outcomes

Primary

MeasureTime frameDescription
Procedure completed successfullyImmediately after procedureWas the procedure completed - yes/no

Secondary

MeasureTime frameDescription
Prevalence of VAS (pain scale) > 5 during procedureImmediately after procedureVAS (Visual analogue scale 0-10, most painful 10) grading by the patient
Prevalence of VAS (pain scale) > 5, five minutes after procedure5 minutes after procedureVAS (Visual analogue scale 0-10, most painful 10) grading by the patient
Acceptable procedure by the patient5 minutes after procedureWas the procedure acceptable by the patient (1-4 when 1 is most acceptable)
Recommended procedure by the patient5 minutes after procedureWould the patient recommend her acquittance the procedure in this outline (1-5, most recommended 5) aquitance (1-5)

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026